10-K: Ardent Health Partners Reports Strong 2024 Results, Navigates Cybersecurity Incident

Ardent Health Partners demonstrates resilience with solid 2024 financial performance despite a significant cybersecurity incident, focusing on growth and operational efficiency.

Summary

• Ardent Health Partners reported its 10-K filing for the fiscal year ended December 31, 2024.
• The company operates 30 acute care hospitals and approximately 280 sites of care across six states.
• In 2024, Ardent served approximately 1.2 million unique patients with about 5.8 million visits.
• The company's growth strategy includes expanding ambulatory and physician alignment initiatives.
• A cybersecurity incident in November 2023 had an adverse pre-tax impact of approximately $74 million.
• Total revenue for 2024 increased by 10.3% to $5.97 billion, driven by a 4.8% increase in adjusted admissions and a 5.1% increase in net patient service revenue per adjusted admission.
• The company centralized corporate services and standardized systems, generating significant cost savings.
• Ardent is focused on growing in mid-sized urban markets and expanding its value-based care contracts, which currently cover more than 220,000 lives.
• The company estimates its serviceable addressable market to be approximately $800 billion in 2020, expected to grow to nearly $1.4 trillion by the end of the decade.
• Ardent is committed to a multi-faceted growth strategy focused on market share, operational excellence, and capital allocation.

Sentiment

Score: 7

Explanation: The document presents a balanced view, highlighting both positive financial performance and challenges faced, such as the cybersecurity incident. The outlook is cautiously optimistic, focusing on growth and efficiency.

Positives

• Ardent achieved a 7.2% increase in Sepsis Bundle compliance, leading to a greater than 13% reduction in Septic Shock mortality.
• The company saw a 33% decrease in catheter-associated urinary tract infections.
• 96% of Ardent's hospitals are performing above the national average with respect to sepsis bundle compliance.
• 81% of Ardent's hospitals that were graded received a Fall 2024 Leapfrog Hospital Safety Grade of A or B, compared to the national average of 56% of hospitals.
• The company acquired 18 urgent care centers across New Mexico and Oklahoma, positioning it to better serve a broad spectrum of acuity throughout the community.
• The company's early results using BioButton in medical surgical units have shown an approximately 9-hour reduction in length of stay.

Negatives

• A ransomware cybersecurity incident in November 2023 had an adverse pre-tax impact of approximately $74 million.
• The company experienced delays in billing claims and obtaining reimbursements and payments through the first quarter of 2024 due to the cybersecurity incident.
• The company faces increasing competition to recruit and retain quality physicians.
• The company's operations are dependent on the efforts, abilities and experience of its management and medical support personnel, such as nurses, pharmacists and lab technicians, as well as its physicians.
• The company is subject to a variety of operational, legal and financial risks associated with outsourcing functions to third parties.

Risks

• Changes in government healthcare programs, including Medicare and Medicaid, could have an adverse effect on revenues and business.
• Reduction in reimbursement rates paid by commercial payors, inability to retain and negotiate favorable contracts with private third party payors, or an increasing volume of uninsured or underinsured patients.
• Security threats, catastrophic events and other disruptions affecting the company's, its service providers or its JV partners' information technology and related systems.
• The highly competitive nature of the healthcare industry and continued industry trends toward clinical transparency and value-based purchasing may impact the company's competitive position.
• Inability to recruit and retain quality physicians and increased labor costs resulting from increased competition for staffing or a continued or increased shortage of experienced nurses, as well as the loss of key personnel, including key members of the management team.
• Changes to physician utilization practices and treatment methodologies and other factors outside the company's control that impact demand for medical services may reduce revenues and ability to grow profitably.
• Third party payor controls designed to reduce costs and other payor practices, including value-based contracting and care coordination, intended to decrease inpatient services, surgical procedure volumes or reimbursement for services.
• Inability to successfully complete acquisitions or strategic JVs or inability to realize all of the anticipated benefits, including anticipated synergies, of past acquisitions or failure to maintain existing relationships with JV partners or enter into relationships with additional healthcare system partners.
• Liabilities because of professional liability and other claims brought against the company's hospitals, physician practices, outpatient facilities or other business operations or against healthcare providers that provide services at its facilities.
• Exposure to certain risks and uncertainties by the JVs through which the company conducts a significant portion of its operations, including risks as a result of its lack of sole decision-making authority.
• Failure to obtain drugs and medical supplies at favorable prices or sufficient volumes.
• Operational, legal and financial risks associated with outsourcing functions to third parties.
• The company's facilities are heavily concentrated in Texas and Oklahoma, which makes it sensitive to regulatory, economic and competitive conditions and changes in those states.
• Economic factors that have affected, and may continue to impact, the company's business, financial condition and results of operations.
• Negative impact of severe weather, climate change, and other factors beyond the company's control, which could restrict patient access to care or cause one or more of its facilities to close temporarily or permanently.
• Risks related to the Ventas Master Lease and its restrictions and limitations on the company's business.
• The impact of the company's significant indebtedness, including its ability to comply with certain debt covenants and other significant operating and financial restrictions imposed on it by the agreements governing its indebtedness, and the effects that variable interest rates and general economic factors could have on its operations, including its potential inability to service its indebtedness.
• The impact of a deterioration of public health conditions associated with a future pandemic, epidemic or outbreak of infectious disease.
• The company's failure to comply with complex laws and regulations applicable to the healthcare industry or to adjust its operations in response to changing laws and regulations.
• The impact of governmental claims or government investigations, payor audits, and litigation, brought against the company's hospitals, physician practices, outpatient facilities or other business operations or against healthcare providers that provide services at its facilities.
• Actual or perceived failures to comply with applicable data protection, privacy and security laws, regulations, standards and other requirements could adversely affect the company's business, results of operations and financial condition.
• Inability to or delay in building, acquiring, selling, renovating or expanding the company's healthcare facilities.
• The company's failure to comply with federal and state laws relating to Medicare and Medicaid enrollment, permit, licensing and accreditation requirements, or the expansion of existing or the enactment of new laws or regulation relating to permit, licensing and accreditation requirements.
• Effects of changes in public healthcare policy, including any reforms that may be undertaken by a new administration, and legal and regulatory restrictions on the company's hospitals that have physician owners.
• Inability to continually enhance the company's hospitals with the most recent technological advances in diagnostic and surgical equipment.
• The company's status as a controlled company.
• Conflicts of interest between the company's controlling stockholder and other holders of its common stock.

Future Outlook

Ardent is committed to driving long-term value creation through targeted market share growth, operational excellence, and disciplined capital allocation, focusing on expanding within existing markets and opportunistically entering new markets.

Management Comments

• The company is focused on centralizing corporate services and standardizing systems to enhance integration and speed of execution.
• The company believes its shift to a centralized operating structure with standardized systems has primed it for ongoing savings, operational improvements, and future growth in new and existing markets.
• The company is committed to diversity, equity, inclusion, and belonging, which is central to its physician and nurse recruitment and retention efforts.

Industry Context

The hospital services and physician and clinical services sectors are highly fragmented, with significant opportunity for continued consolidation across markets and state lines. The U.S. healthcare industry is experiencing a shift to the ambulatory setting due to an effort to contain healthcare spending, migration of lower acuity procedures to lower cost settings, technological advancements, telehealth receptivity by patients, and increased demand for care and facilities that are more convenient and accessible. Commercial and governmental payors are shifting from fee-for-service payment models towards value-based care models.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• However, the document does mention that Ardent's safety ratings consistently exceed the national average, with ten hospitals receiving the Leapfrog Groups prestigious 2024 Top Hospital designation and 81% of its hospitals that were graded receiving a Fall 2024 Leapfrog Hospital Safety Grade of A or B, compared to the national average of 56% of hospitals.
• The document also mentions that Ardent has earned a Gold Stars 9 level designation from Epic, one that measures patient access, patient experience, clinical quality and safety, population health management, physician productivity, and nursing and clinical team productivity.

Legal Proceedings

• Three putative class actions were filed against the Company in the U.S. District Court for the Middle District of Tennessee as a result of the Cybersecurity Incident.
• The cases were consolidated by the District Court on April 24, 2024, under the caption Hodge v. AHS Management Company, Inc., No. 3:23-cv-01308 (M.D. Tenn.).
• On October 4, 2024, the Company executed a settlement agreement to resolve the consolidated class action litigation.
• On October 9, 2024, the District Court preliminarily approved the settlement and set the hearing for the District Courts final approval of the settlement for August 1, 2025.

Related Party Transactions

• The company leases ten of its hospitals from subsidiaries of Ventas pursuant to the Ventas Master Lease.
• During 2022, the company completed the sale of 18 medical office buildings to Ventas in exchange for $204.0 million and concurrently entered into agreements to lease the real estate back from Ventas.
• On May 1, 2023, Pure Health purchased from the unit holders an equity interest representing 25.0% of the total combined voting power of Ardent Health Partners, LLC at the time for approximately $500 million.
• Ventas exercised its tag-along right to sell its proportionate share of interest in both Ardent Health Partners, LLC and AHP Health Partners.
• The company exercised its right to repurchase those shares from Ventas for $26.0 million concurrent with Pure Healths purchase of a minority interest in Ardent Health Partners, LLC.

Stakeholder Impact

• Shareholders: The company is focused on driving long-term value creation.
• Employees: The company is committed to diversity, equity, inclusion, and belonging, which is central to its physician and nurse recruitment and retention efforts.
• Patients: The company is focused on delivering high-quality patient care that exceeds CMS benchmarks.
• Communities: The company is focused on establishing long-term relationships to engage with patients over their lifetime and seek to deliver superior, cost-effective health outcomes.

Next Steps

• Continue to build a leading position in existing markets.
• Opportunistically expand into new markets.
• Continue to invest in digital engagement technologies to acquire new patients and better engage and retain existing patients.
• Continue to leverage Epic, the integrated health information technology system, and other technology solutions to track and segment consumers, allowing the company to execute on patient outreach, acquisition, and engagement initiatives.

Key Dates